Literature DB >> 10807586

C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis.

J Hughes1, M Nangaku, C E Alpers, S J Shankland, W G Couser, R J Johnson.   

Abstract

We studied the role of the C5b-9 membrane attack complex in two models of inflammatory glomerulonephritis (GN) initiated by acute glomerular endothelial injury in Piebold-viral-Glaxo (PVG) complement-sufficient rats (C+), C6-deficient rats (C6-), and rats systematically depleted of complement with cobra venom factor (CVF). GN was induced by performing a left nephrectomy and selectively perfusing the right kidney with either 1) the lectin concanavalin A (Con A) followed by complement-fixing anti-Con A (Con A GN) or 2) purified complement-fixing goat anti-rat glomerular endothelial cell (GEN) antibody [immune-mediated thrombotic microangiopathy (ITM)]. Comparable levels of GEN apoptosis were detected in C+ animals in both models. CVF administration reduced GEN apoptosis by 10- to 12-fold. GEN apoptosis was C5b-9 dependent because PVG C6- rats were protected from GEN loss. Furthermore, functional inhibition of the cell surface complement regulatory protein CD59 by renal perfusion with anti-CD59 antibody in ITM resulted in a 3.5-fold increase in GEN apoptosis. Last, in Con A GN, abrogation of GEN apoptosis preserved endothelial integrity and renal function. This study demonstrates the specific role of C5b-9 in the induction of GEN apoptosis in experimental inflammatory GN, a finding with implications for diseases associated with the presence of antiendothelial cell antibodies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807586     DOI: 10.1152/ajprenal.2000.278.5.F747

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  17 in total

Review 1.  Atypical haemolytic uraemic syndrome and mutations in complement regulator genes.

Authors:  Marie-Agnès Dragon-Durey; Véronique Frémeaux-Bacchi
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

Review 2.  Mechanisms of immune-deposit formation and the mediation of immune renal injury.

Authors:  Masaomi Nangaku; William G Couser
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

Review 3.  Animal models of inherited complement deficiency.

Authors:  S Linton
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

4.  Complement regulator CD59 protects against angiotensin II-induced abdominal aortic aneurysms in mice.

Authors:  Gongxiong Wu; Ting Chen; Aliakbar Shahsafaei; Weiguo Hu; Roderick T Bronson; Guo-Ping Shi; Jose A Halperin; Huseyin Aktas; Xuebin Qin
Journal:  Circulation       Date:  2010-03-08       Impact factor: 29.690

5.  Recombinant membrane-targeted form of CD59 inhibits the growth of choroidal neovascular complex in mice.

Authors:  Nalini S Bora; Purushottam Jha; Valeriy V Lyzogubov; Sankaranarayanan Kaliappan; Juan Liu; Ruslana G Tytarenko; Deborah A Fraser; B Paul Morgan; Puran S Bora
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

6.  Complement mediated apoptosis leads to the loss of retinal ganglion cells in animal model of glaucoma.

Authors:  Purushottam Jha; Himanshu Banda; Ruslana Tytarenko; P S Bora; N S Bora
Journal:  Mol Immunol       Date:  2011-08-06       Impact factor: 4.407

7.  Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage.

Authors:  Giuseppe Castellano; Rita Melchiorre; Antonia Loverre; Pasquale Ditonno; Vincenzo Montinaro; Michele Rossini; Chiara Divella; Michele Battaglia; Giuseppe Lucarelli; Gennaro Annunziata; Silvano Palazzo; Francesco Paolo Selvaggi; Francesco Staffieri; Antonio Crovace; Mohamed R Daha; Maurice Mannesse; Sandra van Wetering; Francesco Paolo Schena; Giuseppe Grandaliano
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

8.  The membrane attack complex (C5b-9) in liver cold ischemia and reperfusion injury.

Authors:  Constantino Fondevila; Xiu-Da Shen; Seiichiro Tsuchihashi; Yoichiro Uchida; Maria Cecilia Freitas; Bibo Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Liver Transpl       Date:  2008-08       Impact factor: 5.799

Review 9.  Pathogenesis and prognosis of thrombotic microangiopathy.

Authors:  Masaomi Nangaku; Hiroshi Nishi; Toshiro Fujita
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

10.  Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation.

Authors:  Bart de Vries; Robert A Matthijsen; Annemarie A J H M van Bijnen; Tim G A M Wolfs; Wim A Buurman
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.